According to Zhitong Finance App, China Resources Pharmaceutical (03320) announced that China Resources Pharmaceutical Holdings Co., Ltd. (China Resources Pharmaceutical Holdings), a wholly-owned subsidiary of the Company, has completed issuing the second issue of 2026 medium-term notes (the second 2026 medium-term note) in China. The second 2026 medium-term note with a principal amount of RMB 1 billion has been issued. The term is three years, and the coupon interest rate is 1.52% per annum.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.